Evidence map›Paper›PMID 35024041›Full record

ArticleFrontiers in immunology2021

Kidney-Draining Lymph Node Fibrosis Following Unilateral Ureteral Obstruction.

Xiaofei Li, Jing Zhao, Said Movahedi Naini, Gianmarco Sabiu, Stefan G Tullius, Su Ryon Shin, Jonathan S Bromberg, Paolo Fiorina, George C Tsokos, Reza Abdi and 1 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.4field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Xiaofei LiTransplantation Research Center, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States.
Jing ZhaoTransplantation Research Center, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States.
Said Movahedi NainiTransplantation Research Center, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States.
Gianmarco SabiuTransplantation Research Center, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States.
Stefan G TulliusTransplantation Research Center, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States.
Su Ryon ShinDivision of Engineering in Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Cambridge, MA, United States.
Jonathan S BrombergDepartments of Surgery and Microbiology and Immunology, Center for Vascular and Inflammatory Diseases, University of Maryland School of Medicine, Baltimore, MA, United States.
Paolo FiorinaTransplantation Research Center, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States.
George C TsokosDivision of Rheumatology and Department of Immunology, Beth Israel Deaconess Medical Center, Boston, MA, United States.
Reza AbdiTransplantation Research Center, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States.
Vivek KasinathTransplantation Research Center, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States.
Brigham and Women's Hospital · USHarvard University · USBeth Israel Deaconess Medical Center · USUniversity of Maryland, Baltimore · US

Funding

Reshaping lymph node stroma for transplant toleranceP01AI153003 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Reza Abdi · 2020 to 2026
$9.3M
TRAINING PROGRAM IN ACADEMIC NEPHROLOGYT32DK007527 · NIDDK · BRIGHAM AND WOMEN'S HOSPITAL · PI BONVENTRE, JOSEPH VINCENT · 1986 to 2021
$8.8M
Lymph Node Structure and Function in Tolerance: Role of LamininsR01AI114496 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI BROMBERG, JONATHAN S · 2015 to 2024
$4.2M
A novel approach to delivering therapeutics in heart transplantationR01HL145813 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI ABDI, REZA · 2019 to 2022
$2.6M
Protection of organ transplant from ischemia reperfusion injuriesR01AI126596 · NIAID · BRIGHAM AND WOMEN'S HOSPITAL · PI ABDI, REZA · 2016 to 2020
$2.6M
Senescent cells drive mt-DNA accumulation and inflamm-agingR01AG064165 · NIA · BRIGHAM AND WOMEN'S HOSPITAL · PI TULLIUS, STEFAN GUNTHER · 2020 to 2024
$2.6M
The microbiota and allograft rejection: novel investigations into the consequences of obesityU01AI132898 · NIAID · BRIGHAM AND WOMEN'S HOSPITAL · PI ALEGRE, MARIA-LUISA, PERKINS, DAVID LINN · 2017 to 2021
$2.3M
IRI, innate immunity and transplant rejectionR01AI156084 · NIAID · BRIGHAM AND WOMEN'S HOSPITAL · PI ABDI, REZA · 2021 to 2025
$2.3M
PI3K-gamma regulates T cell mediated alloimmunityR01HL141815 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI ABDI, REZA · 2018 to 2021
$1.6M
Role of Kidney-Draining Lymph Node in Crescentic GlomerulonephritisK08DK124685 · NIDDK · BRIGHAM AND WOMEN'S HOSPITAL · PI KASINATH, VIVEK · 2020 to 2024
$844k
NHLBI NIH HHS R01 HL141815NHLBI NIH HHS R01 HL145813NIAID NIH HHS P01 AI153003NIAID NIH HHS R01 AI114496NIAID NIH HHS R01 AI126596NIAID NIH HHS R01 AI156084NIAID NIH HHS U01 AI132898NIA NIH HHS R01 AG064165NIDDK NIH HHS K08 DK124685NIDDK NIH HHS T32 DK007527
6 · The paper itself

Abstract

Although the primary organ has been the subject of intense investigation in the field of organ fibrosis over the past several decades, the presence of lymph node fibrosis due to persistent activation of the immune response in its partner organ remains largely unknown. Previously, we demonstrated that activation of the immune response following ischemia-reperfusion injury (IRI) and crescentic glomerulonephritis (CGN) in the kidney was associated with extracellular matrix (ECM) production by fibroblastic reticular cells (FRCs) of the kidney-draining lymph node (KLN). Here, we sought to determine whether FRCs in the KLN become similarly fibrogenic following unilateral ureteral obstruction (UUO) of the kidney. We subjected 6-8-week-old C57BL/6J mice to UUO for 2, 7, and 14 days. We examined the microarchitecture of the kidney and KLN by immunofluorescence staining at each timepoint, and we quantified immune cell populations in the KLN by flow cytometry. The contralateral kidney unaffected by UUO and its partner KLN were used as controls. We found through immunofluorescence staining that FRCs increased production of ECM fibers and remodeled the microarchitecture of the UUO KLN, contributing to fibrosis that mirrored the changes in the kidney. We also observed by flow cytometry that the populations of CD11b

Indexed as

AnimalsFibrosisKidneyLymph NodesLymphocyte ActivationMembrane GlycoproteinsMiceMice, Inbred C57BLPodoplaninTransforming Growth Factor betaUreteral ObstructionMembrane GlycoproteinsPdpn protein, mousePodoplaninTransforming Growth Factor betaacute kidney injurychronic kidney diseasefibroblastic reticular cell (FRC)kidney fibrosislymph noderenal immune homeostasisunilateral ureteral obstruction (UUO)

Identifiers

PMID35024041
PMCPMC8744208
OpenAlexW4200558527

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.